Ligand validation:6FBO

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FBO_EDO_A_412	29%	90%	0.141	0.795	0.53	0.1	-	-	0	0	100%	1
6FBO_EDO_A_411	9%	83%	0.32	0.818	0.31	0.47	-	-	0	0	100%	0.5
6FBO_EDO_A_410	8%	90%	0.337	0.812	0.49	0.13	-	-	1	0	100%	0.5
6FBO_EDO_A_413	2%	87%	0.235	0.48	0.58	0.13	-	-	0	0	100%	1
7RWH_EDO_A_404	76%	86%	0.139	0.975	0.39	0.34	-	-	0	0	100%	0.479
4KTV_EDO_E_401	60%	83%	0.149	0.935	0.44	0.35	-	-	0	0	100%	1
7RWG_EDO_A_403	60%	79%	0.141	0.926	0.37	0.5	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.